ORILANOLIMAB
UNII 1LTT6HMX9N

Substance Identification & Data

This profile provides standardized clinical and technical data for Orilanolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1LTT6HMX9N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2066544-85-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1LTT6HMX9N

CAS Registry Number

2066544-85-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ORILANOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C139561

National Cancer Institute reference terminology for clinical and research data.

INN ID

10825

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-19

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Orilanolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ORILANOLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN FCRN RECEPTOR) (HUMANIZED MONOCLONAL SYNT001 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL SYNT001 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS IGG RECEPTOR FCRN LARGE SUBUNIT P51; SHORT=FCRN (NEONATAL FC RECEPTOR)); HUMANIZED MOUSE MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN (1-444) (VH (MUS MUSCULUS IGHV1-81*01 (93%) (IGHD)-IGHJ1*03 (92%)/HOMO SAPIENS IGHV1-18*01 (78%) (IGHD)-IGHJ6*01 (83%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(226)), CH3(K107>DEL(445))) (119-444)) (132-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV13-85*01 (88%) IGKJ2*01 (92%)/HOMO SAPIENS IGKV1-NL1*01 (83%) IGKJ4*01) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (224-224'':227-227'')-BISDISULFIDE

ORILANOLIMAB [INN]

ORILANOLIMAB [USAN]